Cargando…

CD103 Deficiency Prevents Graft-versus-Host Disease but Spares Graft-versus-Tumor Effects Mediated by Alloreactive CD8 T Cells

BACKGROUND: Graft-versus-host disease (GVHD) remains the main barrier to broader application of allogeneic hematopoietic stem cell transplantation (alloSCT) as a curative therapy for host malignancy. GVHD is mediated by allogeneic T cells directed against histocompatibility antigens expressed by hos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Kechang, Anthony, Bryan A., Yearsly, Martha M., Hamadani, Mehdi, Gaughan, Alice, Wang, Jiao-Jing, Devine, Steven M., Hadley, Gregg A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136479/ https://www.ncbi.nlm.nih.gov/pubmed/21779359 http://dx.doi.org/10.1371/journal.pone.0021968

Ejemplares similares

TGF-β–dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease
por: El-Asady, Riham, et al.
Publicado: (2005)

GITR Activation Induces an Opposite Effect on Alloreactive CD4(+) and CD8(+) T Cells in Graft-Versus-Host Disease
por: Muriglan, Stephanie J., et al.
Publicado: (2004)

Alloreactivity of Virus-Specific T Cells: Possible Implication of Graft-Versus-Host Disease and Graft-Versus-Leukemia Effects
por: Fuji, Shigeo, et al.
Publicado: (2013)

Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect
por: Huang, Ying, et al.
Publicado: (2022)

Donor colonic CD103(+) dendritic cells determine the severity of acute graft-versus-host disease
por: Koyama, Motoko, et al.
Publicado: (2015)

CD8+CD103+ iTregs Inhibit Chronic Graft-versus-Host Disease with Lupus Nephritis by the Increased Expression of CD39
por: Zhang, Xiao, et al.
Publicado: (2019)

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
por: Abedin, Sameem, et al.
Publicado: (2020)

Targeting PKCθ in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potential
por: Bronk, Crystina C., et al.
Publicado: (2012)

Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-versus-host disease
por: Pidala, Joseph, et al.
Publicado: (2022)

Targeting CD83 for the treatment of graft-versus-host disease
por: WANG, XIONGFEI, et al.
Publicado: (2013)

CD4(+)CD8(+) T-Lymphocytes in Xenogeneic and Human Graft-versus-Host Disease
por: Alhaj Hussen, Kutaiba, et al.
Publicado: (2020)

TGF-β-Induced CD8(+)CD103(+) Regulatory T Cells Show Potent Therapeutic Effect on Chronic Graft-versus-Host Disease Lupus by Suppressing B Cells
por: Zhong, Haowen, et al.
Publicado: (2018)

IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease
por: Dwyer, Gaelen K., et al.
Publicado: (2022)

Delayed Anti-CD3 Therapy Results in Depletion of Alloreactive T Cells and the Dominance of Foxp3(+)CD4(+) Graft Infiltrating Cells
por: Goto, R, et al.
Publicado: (2013)

CD4(+)CD25(+) Immunoregulatory T Cells: New Therapeutics for Graft-Versus-Host Disease
por: Cohen, José L., et al.
Publicado: (2002)

CD103 Expression Is Required for Destruction of Pancreatic Islet Allografts by CD8(+) T Cells
por: Feng, Ye, et al.
Publicado: (2002)

Inflammasome activation occurs in CD4(+) and CD8(+) T cells during graft-versus-host disease
por: Talley, Sarah, et al.
Publicado: (2023)

Graft-versus-Host Disease Is Enhanced by Selective CD73 Blockade in Mice
por: Wang, Long, et al.
Publicado: (2013)

Straight tube versus Valsalva graft for valve-sparing operation
por: De Paulis, Ruggero, et al.
Publicado: (2023)

Description of CD8(+) Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer
por: Vieyra-Lobato, Martha R., et al.
Publicado: (2018)

Graft versus host disease in humanized mice is differentially controlled by CD28 and CD80/86 antagonists
por: Poirier, Nicolas, et al.
Publicado: (2012)

Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
por: Hamadani, Mehdi, et al.
Publicado: (2020)

Newly Found Peacekeeper: Potential of CD8+ Tregs for Graft-Versus-Host Disease
por: Wang, Weihao, et al.
Publicado: (2021)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Valve-Sparing Aortic Root Replacement Technique: Valsalva Graft versus Two Straight Tubular Grafts
por: Makkinejad, Alexander, et al.
Publicado: (2023)

Role of CD8 Regulatory T Cells versus Tc1 and Tc17 Cells in the Development of Human Graft-versus-Host Disease
por: Gutiérrez-Hoya, Adriana, et al.
Publicado: (2017)

Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease
por: Amedei, Amedeo, et al.
Publicado: (2013)

Cytolytic CD4(+) and CD8(+) Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)

An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8(+) T Cells
por: Wang, Wei, et al.
Publicado: (2017)

Peripheral tissues reprogram CD8(+) T cells for pathogenicity during graft-versus-host disease
por: Santos e Sousa, Pedro, et al.
Publicado: (2018)

Secreted osteopontin from CD4(+) T cells limits acute graft-versus-host disease
por: Aggarwal, Nupur, et al.
Publicado: (2021)

Impact of Cytomegalovirus and Grafts versus Host Disease on the Dynamics of CD57+CD28−CD8+ T Cells After Bone Marrow Transplant
por: Mendes, Ana Verena Almeida, et al.
Publicado: (2008)

Anti-CD137 mAb Deletes Both Donor CD4(+) and CD8(+) T Cells in Acute Graft-versus-host Disease
por: Kim, Juyang, et al.
Publicado: (2011)

Immunological studies of T-cell receptors. I. Specifically induced resistance to graft-versus-host disease in rats mediated by host T-cell immunity to alloreactive parental T cells
Publicado: (1978)

Photoconversion of Alloreactive T Cells in Murine Peyer’s Patches During Acute Graft-Versus-Host Disease: Tracking the Homing Route of Highly Proliferative Cells In Vivo
por: Jarick, Katja J., et al.
Publicado: (2018)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Reflections on valve-sparing operations utilizing straight tube versus Valsalva grafts
por: Sievers, Hans-Hinrich, et al.
Publicado: (2023)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
por: Kim, Sena, et al.
Publicado: (2020)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
por: Dekker, Linde, et al.
Publicado: (2022)

Novel Concept of CD4-Mediated Activation of Regulatory T Cells for the Treatment of Graft-Versus-Host Disease
por: Schlöder, Janine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4rolq92dnv47m4t7lmrd7mipl1